Therapeutics

Top Story

Adalimumab associated with improvements in nail psoriasis

October 31, 2017

IL-12 therapy elicits encouraging response rates in melanoma

October 25, 2017
Immunopulse IL-12 monotherapy and in combination with pembrolizumab was associated with encouraging response rates and safety data in patients with melanoma who may not…
Meeting News

Platelet-rich plasma injections efficacious for androgenetic alopecia

October 13, 2017
A monthly schedule of platelet-rich plasma injections was safe and efficacious in patients with androgenetic alopecia and may be preferable to injections administered…
In the Journals

UNCOVER-3: Taltz shows durability over long term

September 28, 2017
Patients with moderate-to-severe plaque psoriasis experienced a durable response to Taltz through 108 weeks, according to results of the UNCOVER-3 trial. The trial…
More Headlines »
Advertisement
Advertisement